get a key
steadybase-$ company PTIX
account_id none on file
legal_name Protagenic Therapeutics, Inc.\new
ticker PTIX
cik 1022899
domain protagenic.com
entry_point_account_id none on file
name Protagenic Therapeutics Inc.
exchange OTC
sector Health Care
hq New York, NY, United States
calls 0 filings 9 executives 3 family 0
why_nownone on file
callsnone on file
filings
Office Space The Company is provided free office space consisting of a conference room by the Company Executive Chairman, Dr.

filing / Aug 19, 2026 / receipt

Company is provided free office space consisting of a conference room by the Company Executive Chairman, Dr. Armen. The Company does

filing / Aug 19, 2026 / receipt

Company is working a restructuring plan and related accounting and disclosures. Such procedures are being completed with Audit Committee

filing / Aug 19, 2026 / receipt

August 8, 2025, the Board of Directors (the “Board”) approved a focused restructuring plan (the “Restructuring Plan”) to transition to a virtual operating model and concentrate capital on the Company’s highest-priority clinical program(s).

filing / Aug 14, 2026 / receipt

Workforce reductions also included the certain roles primarily associated with preclinical operations, regulatory affairs, and intellectual property functions.

filing / Aug 14, 2026 / receipt

The Company leases office space for its principal executive office located at 149 Fifth Avenue, Suite 500, New York, New York 10010.

filing / Aug 14, 2026 / receipt

Company leases office space from a company in which an officer has an ownership interest. The lease is believed to be at or below market

filing / Aug 14, 2026 / receipt

If we are not able to raise needed funding under acceptable terms or at all, then we will have to reduce expenses, including the possible options of curtailing operations, abandoning opportunities, licensing or selling off assets, reducing costs to a point where clinical development or other progress is impaired, or ceasing operations entirely.

filing / Aug 14, 2026 / receipt

These cost reduction initiatives could decrease the coverage and price that we receive for our products in the future and could seriously harm our business.

filing / Aug 14, 2026 / receipt

executives
Barrett Evans President and Chief Executive Officer - receipt
Gil Klier director - receipt
Thomas Plotts Interim Chief Financial Officer - receipt
familynone on file
upcomingnone on file
changes
2025-05-19 President and Chief Executive Officer, appointed sec_8k
2010-08-17 Chief Executive Officer, departed sec_8k
2009-12-21 Chief Financial Officer, departed sec_8k
2009-12-21 Interim Chief Financial Officer, appointed sec_8k
2009-10-07 Chief Executive Officer, departed sec_8k
2009-10-07 Chief Marketing Officer, departed sec_8k
2009-10-07 Interim Chief Executive Officer, appointed sec_8k
2008-03-19 Chief Operating Officer, departed sec_8k
2007-08-14 director, appointed sec_8k
2007-01-26 director, departed sec_8k
2006-10-30 Director, departed sec_8k
2006-10-30 President, departed sec_8k
mcp_package_hint
steadybase-$